Skip to main content

Stoke Therapeutics, Inc.

STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001623526

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Stoke Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
126
−3 vs. Q4 2024
Shares held
63.4M
+5.43M (+9.4%) vs. Q4 2024
Total value
$421.6M
−$217.7M (−34.1%) vs. Q4 2024
New holders
24
45 more added
Sold out
27
30 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting STOK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 126 institutions
Q1 2021: 106 institutionsQ2 2021: 97 institutionsQ3 2021: 90 institutionsQ4 2021: 94 institutionsQ1 2022: 99 institutionsQ2 2022: 92 institutionsQ3 2022: 105 institutionsQ4 2022: 107 institutionsQ1 2023: 97 institutionsQ2 2023: 100 institutionsQ3 2023: 97 institutionsQ4 2023: 81 institutionsQ1 2024: 103 institutionsQ2 2024: 115 institutionsQ3 2024: 118 institutionsQ4 2024: 130 institutionsQ1 2025: 126 institutionsQ2 2025: 134 institutionsQ3 2025: 151 institutionsQ4 2025: 183 institutionsQ1 2026: 198 institutionsQ2 2026: 197 institutions
Value heldQ1 2025: $421.6M
Q1 2021: $1.49BQ2 2021: $680.3MQ3 2021: $492.4MQ4 2021: $849.6MQ1 2022: $870.6MQ2 2022: $569.4MQ3 2022: $544.4MQ4 2022: $371.8MQ1 2023: $371.8MQ2 2023: $494.8MQ3 2023: $173.1MQ4 2023: $236.9MQ1 2024: $731.7MQ2 2024: $828.5MQ3 2024: $715.5MQ4 2024: $640.4MQ1 2025: $421.6MQ2 2025: $744.0MQ3 2025: $1.57BQ4 2025: $2.13BQ1 2026: $2.31BQ2 2026: $2.49B
Institutions holding STOK and their total value by quarter
QuarterHoldersValue
Q2 2026197$2.49B
Q1 2026198$2.31B
Q4 2025183$2.13B
Q3 2025151$1.57B
Q2 2025134$744.0M
Q1 2025126$421.6M
Q4 2024130$640.4M
Q3 2024118$715.5M
Q2 2024115$828.5M
Q1 2024103$731.7M
Q4 202381$236.9M
Q3 202397$173.1M
Q2 2023100$494.8M
Q1 202397$371.8M
Q4 2022107$371.8M
Q3 2022105$544.4M
Q2 202292$569.4M
Q1 202299$870.6M
Q4 202194$849.6M
Q3 202190$492.4M
Q2 202197$680.3M
Q1 2021106$1.49B

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Stoke Therapeutics, Inc.; share changes are against Q4 2024.

Institutions holding STOK in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Northern Trust Corp346,664$2.31M0.00%−4,124−1.2%Reduced
Jacobs Levy Equity Management, Inc357,248$2.38M0.01%+357,248New
Erste Asset Management GmbH396,000$2.67M0.03%+396,000New
DAFNA Capital Management LLC443,998$2.95M0.84%+272,901+159.5%Added
Tang Capital Management LLC500,000$3.33M0.18%+200,000+66.7%Added
Bank of America Corp532,884$3.54M0.00%+523,793+5,761.7%Added
Granahan Investment Management Inc660,430$4.39M0.22%+92,741+16.3%Added
Dimensional Fund Advisors LP664,735$4.42M0.00%+125,835+23.4%Added
MPM Oncology Impact Management LP693,988$4.62M0.79%+8,162+1.2%Added
Checkpoint Capital L.P.730,717$4.86M2.67%+425,330+139.3%Added
Geode Capital Management, LLC901,986$6.00M0.00%+24,891+2.8%Added
Assenagon Asset Management S.A.959,603$6.38M0.01%−391,322−29.0%Reduced
State Street Corp1,575,283$10.5M0.00%−12,380−0.8%Reduced
Goldman Sachs Group Inc1,662,039$11.1M0.00%+293,072+21.4%Added
Marshall Wace, LLP2,131,783$14.2M0.02%+1,180,351+124.1%Added
Siren, L.L.C.2,247,347$14.9M0.84%+247,347+12.4%Added
FMR LLC2,541,937$16.9M0.00%+2,376,741+1,438.7%Added
Vanguard Group Inc2,784,202$18.5M0.00%+53,004+1.9%Added
Toronto Dominion Bank3,173,258$21.1M0.05%00.0%Unchanged
Morgan Stanley3,590,825$23.9M0.00%+153,581+4.5%Added
Redmile Group, LLC4,485,981$29.8M2.82%−107,648−2.3%Reduced
Baker Bros. Advisors LP4,633,838$30.8M0.34%00.0%Unchanged
RTW Investments, LP5,123,525$34.1M0.52%00.0%Unchanged
Lynx1 Capital Management LP5,291,929$35.2M12.60%+104,738+2.0%Added
BlackRock, Inc.5,862,436$39.0M0.00%−25,075−0.4%Reduced
Skorpios Trust6,906,181$45.9M99.70%00.0%Unchanged
Norges Bank0$00.00%−314,800−100.0%Sold out
Squarepoint Ops LLC0$00.00%−120,242−100.0%Sold out
Exome Asset Management LLC0$00.00%−113,096−100.0%Sold out
Group One Trading, L.P.0$00.00%−104,411−100.0%Sold out
Panagora Asset Management Inc0$00.00%−104,272−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−86,888−100.0%Sold out
Two Sigma Investments, LP0$00.00%−53,950−100.0%Sold out
Los Angeles Capital Management LLC0$00.00%−43,438−100.0%Sold out
EntryPoint Capital, LLC0$00.00%−31,968−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−29,528−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−28,043−100.0%Sold out
Engineers Gate Manager LP0$00.00%−25,005−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−18,258−100.0%Sold out
Verition Fund Management LLC0$00.00%−15,160−100.0%Sold out
PDT Partners, LLC0$00.00%−13,942−100.0%Sold out
Voya Investment Management LLC0$00.00%−11,100−100.0%Sold out
SG Americas Securities, LLC0$00.00%−10,768−100.0%Sold out
Ameriprise Financial Inc0$00.00%−10,527−100.0%Sold out
Teacher Retirement System of Texas0$00.00%−10,219−100.0%Sold out
Ikarian Capital, LLC0$00.00%−6,798−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−5,770−100.0%Sold out
STRS Ohio0$00.00%−3,800−100.0%Sold out
R Squared Ltd0$00.00%−440−100.0%Sold out
Caitong International Asset Management Co., Ltd0$00.00%−59−100.0%Sold out
IFP Advisors, Inc0$00.00%−6−100.0%Sold out
EverSource Wealth Advisors, LLC0$00.00%−3−100.0%Sold out
Lazard Asset Management LLC0$00.00%−58−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed